Oxford Asset Management’s Inovio Pharmaceuticals INO Stock Holding History

Oxford Asset Management’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,702	Closed	-$121K	–	1834
2019 Q1	$121K	Sell	2,702 -30,190	-92%	-$1.52M	﹤0.01%	1557
2018 Q4	$1.58M	Buy	32,892 +24,615	+297%	+$1.5M	0.04%	606
2018 Q3	$546K	Buy	8,277 +5,959	+257%	+$332K	0.01%	1285
2018 Q2	$110K	Sell	2,318 -323	-12%	-$17.8K	﹤0.01%	1635
2018 Q1	$149K	Sell	2,641 -1,081	-29%	-$58.5K	﹤0.01%	1509
2017 Q4	$189K	Sell	3,722 -6,812	-65%	-$422K	﹤0.01%	1465
2017 Q3	$799K	Buy	10,534 +8,470	+410%	+$630K	0.02%	1038
2017 Q2	$194K	Buy	+2,064	New	+$177K	﹤0.01%	1366

Other funds holding INO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oxford Asset Management's INO Position: Q2 2019 in Review

Oxford Asset Management sold out of Inovio Pharmaceuticals (INO) in Q2 2019, closing a stake of 2,702 shares — an estimated $121K sold.

Oxford Asset Management first reported a position in INO in Q2 2017 and held it in 8 quarters. The position peaked at $1.58M in Q4 2018. 126 funds tracked by Wall St. Rank hold INO as of Q2 2019.

Oxford Asset Management reported no remaining Inovio Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Oxford Asset Management sold 2,702 Inovio Pharmaceuticals shares in Q2 2019, an estimated $121K.
Oxford Asset Management first reported a position in Inovio Pharmaceuticals in Q2 2017 and held it in 8 quarters.
Oxford Asset Management's Inovio Pharmaceuticals position peaked at $1.58M in Q4 2018.
126 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2019.

Based on Oxford Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.